Mercy Health could soon be out of network for Cigna
After months-long negotiations, if an agreement between Mercy Health and Cigna is not reached before April 1, Mercy Health will be considered an out-of-network provider.
According to a release from Mercy Health, they have sought to secure 'appropriate reimbursements' from Cigna. Mercy Health says the current payment agreements 'no longer reflect today's healthcare environment.'
However, Cigna claims the increase requested by Mercy Health is significant and exceeds that of other providers.
'It is disappointing that Bon Secours Mercy Health is choosing to leave our network on April 1,' said a Cigna spokesperson. 'Bon Secours Mercy Health notified us of their intention to leave unless we agree to their significant rate increases across multiple markets. Unfortunately, these increases would make healthcare unaffordable for our customers and their families. We hope that Bon Secours Mercy Health will do what is right for the people we both serve in this community and continue working with us to reach an affordable agreement.'
Cigna reports that Mercy Health 'is demanding' at least a 35% increase over the next 4 years. The company says this increase would then raise costs for those covered by their insurance.
Local impacted hospitals include:
Mercy Health – St. Elizabeth Boardman Hospital
Mercy Health – St. Elizabeth Youngstown Hospital
Mercy Health – St. Joseph Warren Hospital
In its most recent Cost for Caring report, the American Hospital Association reported that hospital prices rose just 2.6% year over year. In contrast, health insurance premiums have risen more than 7%, and Cigna Group, which operates Cigna Healthcare, reported a profit of more than $247 billion in 2024 – an increase of more than 27%.
'Unfortunately, what Cigna pays our doctors, nurses and caregivers is not adequate to account for the cost of providing safe, quality care. We need all of our payer partners to do their part,' Mercy Health stated on its website.
'We have had a positive relationship with Bon Secours Mercy Health, and we want them to stay in our network but only at fair, affordable rates,' Cigna stated. 'We recognize that Bon Secours Mercy Health, like many health care providers across the country, is facing labor shortages and other factors that contribute to cost pressures, but we have a responsibility to keep your health care affordable.'
Mercy Health said patients should receive letters this week alerting patients of negotiations.
More information can be found here.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Cigna beats investor expectations on Evernorth growth
This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Dive Brief: Cigna beat investor expectations on earnings and revenue in the second quarter as the insurer reported strong growth in its Evernorth health services arm. The company reported revenue of $57.8 billion for Evernorth in the second quarter, up 17% year over year. Adjusted income from operations in the unit was $1.7 billion, increasing 5% from last year, according to Cigna's second-quarter earnings released Thursday. Meanwhile, Cigna's health insurance segment is performing within expectations, even as the insurer has seen 'persistently elevated medical costs throughout the year,' COO Brian Evanko said during an earnings call Thursday. Dive Insight: Many insurers have struggled with heightened medical costs in the second quarter, particularly those offering health plans on the Affordable Care Act exchanges as well as in Medicare and Medicaid. But Cigna is likely more insulated from these challenges, given the company's focus on employer-sponsored health plans. The insurer also closed the sale of its Medicare business to Health Care Service Corporation this spring. 'We have intentionally positioned our Cigna Healthcare portfolio with a product mix that has proven favorable in the current environment, as we have no exposure to Medicaid or Medicare,' Evanko said on the call Thursday morning. Cigna's healthcare insurance unit reported $10.8 billion in adjusted revenue, down 18% year over year, largely due to divesting the Medicare business. Adjusted income from operations was $1.1 billion, decreasing 9% from the previous year linked to a higher medical loss ratio — a key marker of spending on patient care. Cigna's MLR was $83.2% in the second quarter, up from $82.3% in 2024 as the company grappled with higher costs in stop-loss insurance. The health insurance unit also faced heightened utilization in individual plans as medical costs increased across the ACA marketplace, CFO Ann Dennison said. 'However, this pressure was manageable due to the smaller relative size of our ACA book, aided by our disciplined pricing actions over the past two years,' she said. On the Evernorth side of the business, adjusted income for pharmacy benefit services was up 2% to $833 million. Adjusted revenue for pharmacy benefit services was up 20%. The positive results for Cigna's pharmacy benefit manager Express Scripts — one of the nation's largest PBMs — comes as the pharmacy middlemen have faced increased scrutiny from regulators and lawmakers for driving up drug costs. Arkansas recently passed a law that would force PBMs to divest pharmacies, but it was put on hold by a federal judge earlier this week. CEO David Cordani said the company is 'quite pleased' with the decision, arguing that while the law is potentially well-intended, it constrains access to care and restrains patient choice. But 'we believe that the industry will continue to operate in an active legislative and regulatory environment' when it comes to PBMs, he said. Overall, Cigna reported revenue of $67.2 billion, increasing 11% from $60.5 billion during the same period last year. Net income was $1.5 billion, relatively flat year over year. The company reaffirmed its outlook on adjusted income from operations of at least $29.60 per share. Recommended Reading Cigna doubles down on GLP-1 support programs with 2 new launches
Fast Company
2 days ago
- Fast Company
Cigna's 2nd quarter profits beat Wall Street's expectations
Cigna beat Wall Street estimate for second-quarter profit on Thursday, helped by strength in its pharmacy benefit management business. It is one of the last health insurers to report quarterly results for the sector, which has been bogged down by persistently high medical costs in government-backed plans. Cigna, however, is insulated from such cost pressures as it recently sold its Medicare business to Health Care Service Corp. It banks more on its pharmacy benefit management and commercial health insurance businesses. 'Our performance in the second quarter reflects our disciplined execution and the strength of our business mix,' said CEO David Cordani. Revenue from its Evernorth healthcare services unit, which includes Cigna's pharmacy benefit management business, rose 17% to $57.83 billion during the quarter. Pharmacy benefit managers help negotiate drug prices and coverage with manufacturers on behalf of employers and health plan clients. PBMs' business practices, however, have drawn increasing scrutiny in recent years from U.S. lawmakers looking to lower drug prices, state attorneys generals and from the Federal Trade Commission, which released a report earlier this year accusing PBMs of inflating drug costs. Cigna's adjusted profit of $7.20 per share topped analysts' average estimate of $7.15 per share, according to data compiled by LSEG. The company maintained its annual adjusted profit forecast of at least $29.60 per share, while analysts expect $29.68 per share. For the quarter, it reported a medical care ratio — the percentage of premiums spent on medical care — of 83.2%, up from 82.3% a year earlier, but in line with analysts' estimate. The company said the increase was due to higher stop-loss medical costs. Stop-loss insurance plans help protect health plan sponsors, typically an employer, when medical claims pass a pre-designated threshold.
Yahoo
2 days ago
- Yahoo
Cigna Group shares rise as Q2 results top estimates
-- The Cigna (NYSE:CI) Group reported better-than-expected second quarter 2025 results on Wednesday, as strong growth in its Evernorth Health Services segment drove revenue significantly higher. Shares rose 1% following the announcement. The health services company posted adjusted earnings of $7.20 per share, exceeding analyst expectations of $7.16. Revenue surged 11% YoY to $67.2 billion, well above the consensus estimate of $62.66 billion. The company reaffirmed its full-year 2025 adjusted earnings outlook of at least $29.60 per share, slightly below analyst projections of $29.69. Evernorth Health Services, which includes pharmacy benefit management and specialty pharmacy services, was the primary growth driver with adjusted revenues increasing 17% to $57.8 billion compared to the same period last year. The segment's pre-tax adjusted income rose 5% to $1.7 billion. "Listening, adapting, and innovating to meet the evolving needs of our patients, customers, and clients enables us to deliver meaningful value," said David M. Cordani, chairman and CEO of The Cigna Group. "Our performance in the second quarter reflects our disciplined execution and the strength of our business mix." The Cigna Healthcare segment saw adjusted revenues decrease 18% to $10.8 billion, primarily due to the divestiture of its Medicare businesses to Health Care Services Corporation in March 2025. Excluding this transaction, the segment's revenue would have increased 7% YoY. The company's medical care ratio rose to 83.2% from 82.3% in the year-ago quarter, reflecting expected higher stop loss medical costs. Total pharmacy customers increased 3% from December 31, 2024, to 121.9 million, while total medical customers decreased 6% to 18 million, primarily due to the HCSC transaction. Related articles Cigna Group shares rise as Q2 results top estimates These Under-the-Radar Stocks Offer Better Risk-Reward Ratio Than Nvidia Surge of 50% since our AI selection, this chip giant still has great potential Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
